Especially since this is just the application for Breakthrough Therapy for Rett syndrome.
We still have Fragile X syndrome to come (which by the way is over 60x more common in the USA) - much wider market to sell to. And concussion after that.
The SP has essentially halved based on ~1/3 of NEU's possible business. Nothing is stopping NEU from gathering more evidence and applying again after speaking with the FDA. As mentioned by a previous poster a few days ago some other biotechs have had to apply 3 times before finally getting it.
Great buying op i think, or am i missing something?
- Forums
- ASX - By Stock
- Ann: Neuren receives response to request for Breakthrough Therapy
Especially since this is just the application for Breakthrough...
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$13.35 |
Change
-0.305(2.23%) |
Mkt cap ! $1.696B |
Open | High | Low | Value | Volume |
$13.68 | $13.68 | $13.11 | $3.390M | 254.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 53 | $13.34 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.35 | 1682 | 25 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 28 | 13.340 |
5 | 377 | 13.330 |
5 | 596 | 13.320 |
5 | 371 | 13.310 |
6 | 993 | 13.300 |
Price($) | Vol. | No. |
---|---|---|
13.360 | 1820 | 19 |
13.370 | 765 | 6 |
13.380 | 531 | 5 |
13.390 | 946 | 6 |
13.400 | 2233 | 4 |
Last trade - 15.56pm 18/09/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |